FOXO Technologies(us:FOXO)

    0.2720

    -3.20%

    Updated on 2024-12-23

    Open:0.2902
    Close:0.2720
    High:0.2970
    Low:0.2652
    Pre Close:0.2810
    Volume:730203.00
    Amount:207880.64
    Turnover:3.84%
    Shares:19.03M
    MarketCap:5.17M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-30163094632.74%425
    2024-03-31143865274.32%322
    2023-12-31193486544.56%269
    2023-09-30171419900.24%242
    2023-06-301712999492.80%243
    2023-03-311910605873.87%926
    2022-12-31156502572.36%608
    2022-09-3038409212912.39%7229
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Cantor Fitzgerald, L. P.1904762.13%0
    2024-03-31Clear Street Llc500000.56%50000
    2024-03-31Corbin Capital Partners, L.P.274800.31%0
    2024-03-31Geode Capital Management, Llc248640.28%0
    2024-03-31Vanguard Group Inc242380.27%0
    2024-03-31Virtu Financial Llc235630.26%23563
    2024-03-31State Street Corp200300.22%0
    2024-03-31Jane Street Group, Llc120930.14%12093
    2024-03-31Atalaya Capital Management Lp117780.13%0
    2024-03-31Tower Research Capital Llc (Trc)17500.02%19012.18%

    About

    FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. It operates through the FOXO Labs and FOXO Life segments. The FOXO Labs segment refers to the research and development and is commercializing proprietary epigenetic biomarker technology. The FOXO Life segment is involved in combining life insurance with a dynamic molecular health and wellness platform. The company was founded in 2020 and is headquartered in Minneapolis, MN.
    Address:729 North Washington Avenue,Suite 600

    Market Movers